Global Antidiabetics Market Size & Outlook, 2023-2030

The antidiabetics industry worldwide is expected to reach a projected revenue of US$ 137,586.7 million by 2030. A compound annual growth rate of 9.7% is expected of the worldwide antidiabetics industry from 2024 to 2030.
Revenue, 2023 (US$M)
$72,195.9
Forecast, 2030 (US$M)
$137,586.7
CAGR, 2024 - 2030
9.7%
Report Coverage
Worldwide

Global antidiabetics market highlights

  • The global antidiabetics market generated a revenue of USD 72,195.9 million in 2023 and is expected to reach USD 137,586.7 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 9.7% by 2030.
  • In terms of segment, glp-1 receptor agonists accounted for a revenue of USD 25,570.1 million in 2023.
  • GLP-1 Receptor Agonists is the most lucrative drug class segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.
  • Country-wise, Saudi Arabia is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 72,195.9 million
Market revenue in 2030USD 137,586.7 million
Growth rate9.7% (CAGR from 2023 to 2030)
Largest segmentGlp-1 receptor agonists
Fastest growing segmentGLP-1 Receptor Agonists
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationGLP-1 Receptor Agonists, DPP- 4 Inhibitors, SGLT2 Inhibitors, Others Drug Class, Insulin

Other key industry trends

  • In terms of revenue, the North America accounted for 41.5% of the global antidiabetics market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Saudi Arabia is the fastest growing regional market and is projected to reach USD 731.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Antidiabetics Market Companies

Name Profile # Employees HQ Website

Global antidiabetics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antidiabetics market will help companies and investors design strategic landscapes.


Glp-1 receptor agonists was the largest segment with a revenue share of 35.42% in 2023. Horizon Databook has segmented the Global antidiabetics market based on glp-1 receptor agonists, dpp- 4 inhibitors, sglt2 inhibitors, others drug class, insulin covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Antidiabetics Drug Class Outlook (Revenue, USD Million, 2018-2030)
    • GLP-1 Receptor Agonists
    • DPP- 4 Inhibitors
    • SGLT2 Inhibitors
    • Others Drug Class
    • Insulin
      • Long-acting insulin
      • Premix insulin
      • Fast-acting insulin
      • Human insulin
  • Global Antidiabetics Diabetes Type Outlook (Revenue, USD Million, 2018-2030)
    • Type 1
    • Type 2
  • Global Antidiabetics Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Global Antidiabetics Route of Administration Outlook (Revenue, USD Million, 2018-2030)
    • Oral
    • Subcutaneous
    • Intravenous

Reasons to subscribe to Global antidiabetics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global antidiabetics market databook

  • Our clientele includes a mix of antidiabetics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global antidiabetics market, including forecasts for subscribers. This global databook contains high-level insights into Global antidiabetics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global antidiabetics market size, by regions, 2018-2030 (US$M)

Top 10 countries: Antidiabetics market size, 2023 (US$M)

Global antidiabetics market share, by drug class, 2023 & 2030 (%, US$M)

Antidiabetics market: Opportunity assessment by country

Global antidiabetics market, by region, 2023 (US$M)

Global antidiabetics market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more